This is good.......I think. Geron will present preclinical data related to imetelstat, the company's telomerase inhibitors. April 3rd, the results will be posted on there website. Results must be good. If not why do a presentation. Also they want the ok to be able sell 100 million more share. If results are looking good, the share price will go up and Geron sells some shares. Making money for phase 3 trials. Closed down at $1.695 on only 732,431 shares. The three month avg volume is 1 million shares.
Good luck in this rigged casino,
No comments:
Post a Comment